Response to: Comment on “Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema”

Response to: Comment on “Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema”

Saved in:

Bibliographic Details
Main Authors:	Matthias Peter Hilty, Stefanie Zügel, Michele Schoeb, Katja Auinger, Christoph Dehnert, Marco Maggiorini
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2018/8036759
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema
by: Matthias Peter Hilty, et al.
Published: (2016-01-01)

Comment on “Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema”
by: Gaurav Sikri, et al.
Published: (2017-01-01)

Soluble urokinase plasminogen activator receptor: a novel biomarker of pediatric community-acquired and hospitalacquired pneumonia
by: Muhammad Said El-Mekkawy, et al.
Published: (2022-02-01)

Effect of Plasma Soluble Urokinase-Type Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 Levels in the Plasma of Babylon Women with Breast Cancer
by: Sheerin H. Abbas, et al.
Published: (2025-01-01)

Clinical value of soluble urokinase-type plasminogen activator receptor in predicting sepsis-associated acute kidney injury
by: Wenwen Zhang, et al.
Published: (2024-12-01)

Serum soluble urokinase type plasminogen activated receptor and focal segmental glomerulosclerosis: a systematic review and meta-analysis
by: Kehu Yang, et al.
Published: (2019-10-01)

Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic biomarker in acutely admitted patients with atrial fibrillation
by: Frederik Dencker Wisborg, et al.
Published: (2025-04-01)

Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis
by: Jiwon M. Lee, et al.
Published: (2019-01-01)

The Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as Predictive Tool in Hospitalised Patients With Community‐Acquired Pneumonia (CAP)
by: Lisa Hessels, et al.
Published: (2025-06-01)

Can serum soluble urokinase plasminogen activator receptor be an effective biomarker in comparing the inflammatory response between laparoscopic and open appendectomy?
by: Basak Erginel, et al.
Published: (2023-06-01)

Association of soluble urokinase plasminogen activator receptor and epidermal growth factor with histopathological findings of kidney biopsy: a single-center study
by: Eman Nagy, et al.
Published: (2025-07-01)

Urokinase-Type Plasminogen Activator System in Norm and in Life-Threatening Processes (Review)
by: Elena V. Kugaevskaya, et al.
Published: (2018-12-01)

Increased Serum Soluble Urokinase Plasminogen Activator Receptor Predicts Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure
by: Zuxiong Huang, et al.
Published: (2019-01-01)

Proteomics‐Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long‐Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study
by: Adithya K. Yadalam, et al.
Published: (2025-05-01)

Soluble urokinase-type plasminogen activator receptor strongly predicts global mortality in acute heart failure patients: insight from the STADE-HF registry
by: Fabien Huet, et al.
Published: (2021-06-01)

Point-of-care prognostication in moderate Covid-19: Analytical validation and prognostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid test.
by: Arjun Chandna, et al.
Published: (2023-01-01)

Involvement of Urokinase-Type Plasminogen Activator Receptor in the Formation of a Profibrotic Microenvironment in the Epicardial Region
by: K. V. Dergilev, et al.
Published: (2021-12-01)

Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis
by: Thomas Kallemose, et al.
Published: (2020-07-01)

Role of Urokinase-Type Plasminogen Activator Receptor in the Regulation of Angiogenic Properties of Sca1+ Vasculogenic Progenitor Cells
by: К. V. Dergilev, et al.
Published: (2022-04-01)

Estramustine Phosphate Inhibits TGF-β-Induced Mouse Macrophage Migration and Urokinase-Type Plasminogen Activator Production
by: Sonja S. Mojsilovic, et al.
Published: (2018-01-01)

Urokinase plasminogen receptor and the fibrinolytic complex play a role in nerve repair after nerve crush in mice, and in human neuropathies.
by: Cristina Rivellini, et al.
Published: (2012-01-01)

Study the effect of urokinase-type plasminogen activator (UPA) and some biochemical parameters in Iraqi hemodialysis patients with type 2 diabetes
by: Fatima Ali Essa Al-Sudani, et al.
Published: (2024-01-01)

WCN25-2746 Urokinase plasminogen activator receptor upregulation in lupus nephritis associates with distinct interferon hub genes in stressed podocytes
by: Björn Tampe, et al.
Published: (2025-02-01)

Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System
by: Maurizio Cammalleri, et al.
Published: (2017-01-01)

Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View
by: Andreas Kronbichler, et al.
Published: (2016-01-01)

Oxygen metabolism abnormalities and high-altitude cerebral edema
by: Zhi Li, et al.
Published: (2025-03-01)

Hippocampal Viral-Mediated Urokinase Plasminogen Activator (uPA) Overexpression Mitigates Stress-Induced Anxiety and Depression in Rats by Increasing Brain-Derived Neurotrophic Factor (BDNF) Levels
by: Amine Bahi, et al.
Published: (2024-12-01)

High Altitude Pulmonary Edema. Case Report and Bibliography Review
by: Edgar Ernesto Romo Pinos, et al.
Published: (2018-02-01)

Clinical Profile of High-Altitude Cerebral Edema: A Case Series
by: Manish Bhartiya, et al.
Published: (2025-03-01)

Standardization of Methods for Early Diagnosis and On-Site Treatment of High-Altitude Pulmonary Edema
by: Qiquan Zhou
Published: (2011-01-01)

COVID-19 Happy Hypoxemia and High-Altitude Pulmonary Edema - Pathophysiological Links?
by: Harsha Jain, et al.
Published: (2021-07-01)

Lung Ultrasound Is Accurate for the Diagnosis of High-Altitude Pulmonary Edema: A Prospective Study
by: Weibo Yang, et al.
Published: (2018-01-01)

A machine learning-based severity stratification tool for high altitude pulmonary edema
by: Luobu Gesang, et al.
Published: (2025-04-01)

The impact of the Gannon Storm of May 2024 on the radiation fields at aviation altitudes and in low earth orbits
by: Kai Schennetten, et al.
Published: (2024-11-01)

Gut opportunistic pathogens contribute to high-altitude pulmonary edema by elevating lysophosphatidylcholines and inducing inflammation
by: Xianduo Sun, et al.
Published: (2025-07-01)

Plasminogen activators in acute management of thrombosis
by: E. O. Taratukhin
Published: (2013-06-01)

Urokinase Attenuates Pulmonary Thromboembolism in an Animal Model by Inhibition of Inflammatory Response
by: Ying Shi, et al.
Published: (2018-01-01)

AZU1 as a DNA Methylation-Driven Gene: Promoting Oxidative Stress in High-Altitude Pulmonary Edema
by: Qiong Li, et al.
Published: (2025-07-01)

Acute Lung Edema as a Presentation of Severe Acute Reentry High-Altitude Illness in a Pediatric Patient
by: Alfredo Merino-Luna, et al.
Published: (2020-01-01)

Streptolysin O accelerates the conversion of plasminogen to plasmin
by: Di Tang, et al.
Published: (2024-11-01)